Pharmaceuticals

Novo Nordisk cuts cash prices for Wegovy, Ozempic

Read more

Trump strikes deal with Eli Lilly, Novo Nordisk

Read more

Trump deals with Lilly, Novo Nordisk could broaden obesity drug access

Read more

Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle

Read more

Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug prices

Read more

Wegovy, Ozempic maker Novo Nordisk Q3 earnings

Read more

Kimberly-Clark to acquire Kenvue

Read more

What’s next for the weight loss drug market: pills, rivals, insurance

Read more

FDA to speed up generic drug approvals as Trump targets drug costs

Read more

Novartis Avidity Biosciences in talks

Read more